PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
The Laboratory Branch Consortium includes a group of international organizations with expertise in various
aspects of laboratory capacity development. FY 2009 funds were temporarily placed in the CDC,
International Laboratory Branch Consortium pending the identification of appropriate implementing partners.
This action will re-program funds from the Laboratory Branch Consortium to one of the partners, Clinical
and Laboratory Standards Institute (CLSI), to carry out activities that will improve laboratory practices in
Vietnam.
The International Laboratory Branch Consortium activity narrative that refers directly to CLSI remains the
same.
This is a continuing activity from FY 2008.
The Laboratory Coalition is a loosely-knit group of international organizations with expertise in various
aspects of laboratory capacity development. The coalition members include the Association of Public Health
Laboratories (APHL), the American Society for Clinical Pathology (ASCP), the American Society for
Microbiology (ASM), and the Clinical and Laboratory Standards Institute (CLSI). All have worked closely in
various PEPFAR-supported countries over the past five years. This activity narrative explains projects and
activities planned for ASCP, ASM, and CLSI; an explanation of the activities can be found in the APHL
narrative. In FY09, laboratory coalition partners will support curriculum development, provide technical
assistance (TA) for the development of a national laboratory accreditation program, and will assess and
make recommendations for improvements to TB culture practices.
ASCP is focused on improving global health by exploring, identifying, and implementing innovative methods
and partnerships that improve laboratory practices. ASCP staff and volunteers provide technical assistance
and build laboratory infrastructure in countries affected by HIV/AIDS. Over the past five years, ASCP has
developed modular, five-day training packages for CD4 determination, clinical chemistry, and hematology.
Training packages consist of lectures (Power Point presentations), a participant's manual, participant
supplementary materials (i.e., procedures, atlases, job aids), an instructor's manual, an instructor's guide
with support notes, and an electronic copy of the training package (CD-ROM). Hands-on instrument training
is coordinated by ASCP through in-country vendors. Packages have been extensively field tested in various
countries by a cadre of skilled trainers. In FY08, ASCP will conduct a review of the current training curricula
in these three areas and will adapt their training packages to the Vietnam setting. In FY09, ASCP will deliver
the training curriculum to a targeted audience, who will serve as future master trainers and disseminate the
training to sites where care and treatment monitoring is currently provided.
In FY09, ASCP will also work towards improving the quality of training provided to students attending
medical laboratory degree programs in Vietnam through a program known as Pre-Service Curriculum
Development. The ASCP Pre-Service Work Group is comprised of educators from seven universities and
schools of medical technology. This is a 24-month, two-phase program. The first phase includes the
assessment of current training materials, a curriculum development workshop to be attended by key faculty
members and school deans, 700 hours of professional curriculum development by U.S.-based university
partners, and a curriculum finalization workshop attended by key stakeholders, faculty, and school directors.
The second phase includes a monitoring and evaluation activity (observing new materials being taught), an
additional 300 hours of professional curriculum development/finalization by the ASCP, and a two-month
mentorship with ASCP consultants.
The American Society for Microbiology is the world's largest and oldest scientific society of individuals
interested in the microbiological sciences. The Society's mission is to advance microbiological sciences
through the pursuit of scientific knowledge and dissemination of the results of fundamental and applied
research. ASM has more than 43,000 members worldwide (more than 5,000 of these are clinical
microbiologists); the members represent 26 disciplines of microbiological specialization, including a division
for microbiology educators. ASM, via its International Laboratory Capacity Building Program, supports
global health programs by ensuring that laboratories possess the necessary organizational and technical
infrastructure to provide quality laboratory testing and results in support of infectious disease prevention,
care, and treatment. Since 2006, ASM has worked closely with the CDC Global AIDS Program and
PEPFAR by providing onsite technical assistance and training through carefully chosen experts from their
membership roles. ASM's activities specifically include improving the quality and capacity of infectious
disease diagnosis by training and mentoring local laboratorians on implementing newer technologies and
optimizing quality-assured laboratory testing procedures. ASM is currently supporting: PEPFAR programs in
Botswana, Côte d'Ivoire, Haiti, Kenya, Mozambique, Namibia, Nigeria, and Zambia; CDC International
Emerging Infections programs in Guatemala, Thailand, Kenya, and China; and workshops for the African
Centre for Integrated Laboratory Training in South Africa .
In FY09, ASM will provide TA to improve the following diagnostic training programs: Bach Mai Hospital in
Hanoi for opportunistic infections (OI), the National Institute for Dermatology and Venereology (NIDV) for
sexually transmitted infections, and the National TB Hospital for TB. ASM will conduct initial assessments of
current diagnostic testing capacities and training programs. To update the AFB smear microscopy training
package, ASM will use the recently published WHO/CDC generic package as a resource. For distribution of
new packages, ASM will develop master trainers from the existing facility staff. To ensure TB liquid culture
is conducted in Vietnam at an internationally accepted standard, ASM will conduct assessments of the
culture laboratory at the National TB Hospital and Pham Ngoc Thach Hospital. These will be used to make
recommendations to ensure liquid culture is conducted in a way that is safe for both the laboratory staff and
the environment. This might include training, infrastructure improvements, and/or procurement of new
equipment.
The Clinical and Laboratory Standards Institute is a global, nonprofit, standards-developing organization
that identifies best practices, voluntary consensus standards, and guidelines through a unique consensus
process that balances the viewpoints of government, industry, and health professions. CLSI documents
"best practices", which are used in over 55 countries worldwide, and are translated into several languages.
Good laboratory practices prove to be cost-effective, promote reliable and accurate results, contribute to
Activity Narrative: good patient care, and promote a positive attitude towards testing from a patient's perspective. Guided by
our membership and accepted clinical and laboratory standards and guidelines, CLSI is committed to
facilitating the development of quality systems in the laboratory and providing on-going advisement to
sustain quality improvements. CLSI will build capacity through the provision of laboratory standards and
guidelines, and provide technical assistance, training, and technology transfer to individuals and
organizations. CLSI is currently involved in building laboratory capacity in Namibia, Nigeria, Ethiopia, Cote
D'Ivoire, and Tanzania.
One objective of the PEPFAR laboratory program is to enhance the overall quality of laboratory testing in
health care and public health laboratories across Vietnam. In FY09, CLSI will provide technical assistance
to Vietnam's Ministry of Health's Department of Medical Administration (DMA) to develop a national
program for laboratory accreditation. This program does not currently exist in Vietnam, but will be clearly
outlined in the National Laboratory Strategic Plan (NLSP), currently under development with PEPFAR
support.
New/Continuing Activity: New Activity
Continuing Activity:
Table 3.3.16: